Simons Ezajobo
ID: UNCST-2021-R012010
|
Uptake of HIV Testing Services through Assisted Partner Notification (APN) among Men in Wakiso District.
REFNo: HS2537ES
2.To understand the preferred partner notification approaches to help men feel more comfortable and confident in getting tested for HIV.,1.To assess the experience of males during the process of HIV testing services provision.,To identify barriers and facilitators to HIV testing among men in Uganda,
|
Uganda |
2022-11-08 13:23:56 |
2025-11-08 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Catriona Waitt John
ID: UNCST-2019-R001068
|
PHARMACOKINETICS OF DRUGS USED TO TREAT UNCOMPLICATED MALARIA IN BREASTFEEDING MOTHER-INFANT PAIRS
REFNo: HS2392ES
Primary Objectives;
1. To define transfer of lumefantrine and its active metabolite, desbutyl-lumefantrine from mother to breastfed infant.
2. To determine the clearance, AUC, and volume of distribution of lumefantrine and desbutyl-lumefantrine
Secondary Objectives
1. To describe covariates influencing drug exposure in maternal plasma, breast milk and infant plasma
2. To develop a population pharmacokinetic model including the breast and the infant as compartments, which will both enable optimal use of sparse data from future studies and enable simulations of different doses or combinations.
3. To assess depression and anxiety levels among breastfeeding mothers on first line antimalarial drugs.
4. Beliefs about medicines in breastfeeding mothers receiving antimalarial treatment
|
UK |
2022-11-04 16:05:41 |
2025-11-04 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Dinah Amongin
ID: UNCST-2020-R014663
|
Innovations for continuity of HIV, TB and malaria services during the COVID-19 pandemic in Uganda
REFNo: HS2477ES
The goal of this research is to collate and assess the impact of innovative people-centred and community-based approaches adopted during the covid-19 pandemic to ensure continued HIV, TB and malaria services in Uganda. This will inform the ongoing and future pandemic/epidemic response actions.
Specific objectives are:
1. To identify innovations used to mitigate the impact of the covid-19 pandemic on the provision, access, and utilization of HIV, TB and Malaria services in Uganda.
2. To assess the impact of innovations to mitigate the impact of the COVID-19 pandemic on HIV, TB, and Malaria services provision, access, and utilization.
3. To document the lessons learnt in innovating to mitigate the impact of COVID-19 on HIV, TB and malaria services in Uganda during the pandemic.
|
Uganda |
2022-11-03 12:21:51 |
2025-11-03 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Albert Munyeshyaka
ID:
|
Cosmological studies in modified Gauss-Bonnet gravity
REFNo: NS434ES
To determine evolution of overdensities and velocity perturbations in f (G) grav- ity,To analyse perturbations of a Chaplygin gas model in f (G) gravity,To analyse covariant velocity and overdensities of quasi-Newtonian cosmological model in f (G) gravity,To derive evolution of 1 + 3 covariant linear perturbation equations in f (G) gravity.,The aim of this study is to explore cosmological studies in modified Gauss-Bonnet gravity.,
|
Rwanda |
2022-11-03 12:09:30 |
2025-11-03 |
Natural Sciences |
Non-Clinical Trial |
Degree Award |
|
MICHAEL JACKSON WAKWABUBI
ID:
|
Financial distress in local governments in Uganda
REFNo: SS1429ES
To establish the relationship between local government delivery system and financial distress in local governments in Uganda
To assess the relationship between revenue concentration and financial distress in local governments in Uganda
To examine the relationship between revenue concentration, local governance, corruption and LG delivery system in local governments in Uganda
To assess the mediating effect of LG delivery system in the relationship between revenue concentration, local governance, corruption and financial distress in local governments in Uganda
To establish the relationship between local governance and financial distress in local governments in Uganda
To establish the relationship between corruption and financial distress in local governments in Uganda
|
Uganda |
2022-11-03 11:38:10 |
2025-11-03 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Hannah Kibuuka
ID: UNCST-2020-R014355
|
‘Remdesivir: Monitored Emergency Use for Filoviral Disease’
REFNo: HS2531ES
To offer patients with laboratory-confirmed filovirus disease (e.g. Ebola virus [EBOV], Bundibugyo virus [BDBV], Marburg virus [MARV] disease, and Sudan virus [SUDV]) under the clinical supervision of the protocol Principal Investigator or their designated physicians, access to treatment with Remdesivir under monitored conditions.
|
Uganda |
2022-11-02 17:30:52 |
2025-11-02 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Eugene Ruzagira
ID: UNCST-2023-R008282
|
Efficacy, Safety and Effectiveness of Injectable Cabotegravir/Rilpivirine in Improving HIV Control in Sub-Saharan Africa: A pragmatic Phase 3 Open-label Randomized Controlled Trial.
REFNo: HS2475ES
Primary objective:
To demonstrate the non-inferior efficacy of switching to every 2 months (Q2M) intramuscular (IM) injection of cabotegravir (CAB) long acting (LA) plus rilpivirine (RPV) LA compared with continuation of first-line oral ART over 12 months in people living with HIV (PLHIV) with a history of, or at risk of, sub-optimal HIV control.
Secondary objectives:
1) To demonstrate the antiviral activity and the impact on retention in HIV care of switching to Q2M CAB LA + RPV LA compared with continuation of oral ART over 12 and 24 months in PLHIV with a history of, or at risk of, sub-optimal ART adherence or engagement in care.
2) To demonstrate the immunological activity of switching to Q2M CAB LA + RPV LA compared with continuation of oral ART over 12 and 24 months in PLHIV with a history of, or at risk of, sub-optimal ART adherence or engagement in care. This will be measured through change in CD4+ T cell count and incidence of HIV disease progression.
3) To evaluate the safety and tolerability of switching to Q2M CAB LA + RPV LA compared to continuation of oral ART.
4) To assess genotypic viral resistance in participants experiencing protocol-defined confirmed virological failure (plasma HIV-1 RNA >200 c/ml) and its impact on future treatment options including proportion who resuppress on dolutegravir.
5) To evaluate the effect of Q2M CAB LA + RPV LA on health-related quality of live, treatment satisfaction and treatment adherence. To describe cost-effectiveness and acceptability of the regimen.
|
Uganda |
2022-11-02 17:27:11 |
2025-11-02 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
Clare Bangirana Ahabwe
ID: UNCST-2021-R012842
|
Violence Against Children and Youth Surveys (VACS) Cognitive Testing of Gender Attitude and Norm Measures Among Youths in Humanitarian Settings in Uganda
REFNo: SS1486ES
• To evaluate participants’ interpretation of the gender measures, consider and weigh relevant aspects of their lives and formulate a response based on those considerations.
• To test and refine gender measures that are understandable to 13-24-year-old study participants for inclusion in the core VACS questionnaire and future VACS administration.
• To identify context specific relevance of proposed gender measures in the administration of VACS in a humanitarian setting within Uganda.
|
Uganda |
2022-11-02 10:14:05 |
2025-11-02 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Achilles Kiwanuka
ID:
|
Comparative Analysis of Health Information Systems Approaches in Use in Uganda
REFNo: HS2521ES
1. Describe the achievements, challenges, lessons learned and prospects for using the paper based HMIS, Smart Paper Technology and fully digitalized approaches for managing health information in Uganda.
2. Assess performance, usability and functionality of the fully digitalised and paper based HMIS approaches at the community level and Smart Paper Technology at the health facility level using the Performance of Routine Information System Management (PRISM) framework.
3. Analyze the cost benefit of using Smart Paper Technology and fully digitalised approaches of health information systems in Uganda.
4. Analyze the cost effectiveness of using Smart Paper Technology and fully digitalised approaches over the paper based HMIS for managing health information in Uganda.
5. Assess the impact on the budget after adopting Smart Paper Technology or fully digitalised approaches for managing health information with a focus to community health information systems in Uganda.
6. Evaluate the scalability of the Smart Paper Technology and fully digitalised approaches considering geographic scale and integration with other HMIS components
|
Uganda |
2022-11-01 18:27:02 |
2025-11-01 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Okee Margaret Jill
ID:
|
USING INFORMATION AND COMMUNICATION TECHNOLOGY FOR LEARNING ENHANCEMENT IN HIGHER EDUCATION INSTITUTIONS: CASE OF KAMPALA METROPOLITAN AREA
REFNo: SIR144ES
1.To determine the relationship between e-learning pedagogy and learning enhancement.
2.To determine the relationship between motivation of students and learning enhancement.
3.To determine the relationship between ICT systems characteristics and learning enhancement.
4.To determine the combined effects of the relations of e-learning pedagogy and ICT systems characteristics on motivation of students.
5.To determine the combined effects of the relationships of e-learning pedagogy, motivation of students and ICT characteristics on learning enhancement.
6.To establish the intermediating role of the e-learning policy between institutional support and learning enhancement.
|
Uganda |
2022-10-31 15:34:11 |
2025-10-31 |
Engineering and Technology |
Non-Clinical Trial |
Degree Award |
|
Charles Drago Kato Drago
ID: UNCST-2021-R012897
|
Development and evaluation of a community-based bat-human interface monitoring program for zoonotic spillover early warning and response in Uganda
REFNo: HS2428ES
1) To build a community-created map of bat-human interfaces in Bundibugyo.
2) Establish an ecological baseline on the bats and human- bat interactions in Bundibugyo district
3) Establishing a sustainable bat-human interface monitoring program
|
Uganda |
2022-10-31 15:31:18 |
2025-10-31 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
.JPG)
|
Dr. Betty Kwagala
ID: UNCST-2022-R009048
|
Economic and Health impact and the resilience of last mile populations in artisanal and small- scale mining unplanned settlements in Sub-Saharan Africa before, during and after COVID-19: The case of Ghana and Uganda
REFNo: SS1496ES
4) To identify, co-develop and pilot test one context specific priority intervention to strengthen last mile adolescent girls’ resilience during future crises,3) To describe the interventions proposed by these populations and literature for strengthening adolescent girls’ coping skills and fostering resilience during the COVID-19 pandemic recovery and their applicability to future crises,2) To identify the coping mechanisms adolescent girls used to support their health and economic wellbeing during the pandemic.,1) To assess the economic and health impacts of the COVID-19 pandemic on the last-mile adolescent girls living in unplanned mining communities in Uganda and Ghana. To describe and assess the economic, health impacts and the resilience of adolescent girls in unplanned mining communities and coping mechanisms during the COVID-19 pandemic to support their future resilience and ability to cope during recovery and in similar future crises.
|
Uganda |
2022-10-28 15:09:30 |
2025-10-28 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Hannah Kibuuka
ID: UNCST-2020-R014355
|
A randomized, double-blind, positive-controlled Phase III clinical trial to
evaluate the efficacy and safety of SCTV01E (A COVID-19 Alpha/Beta/Delta/Omicron Variants S-Trimer Vaccine) in population previously unvaccinated with COVID-19 vaccine and aged ≥18 years
REFNo: HS2508ES
To evaluate the protective efficacy of SCTV01E against symptomatic COVID-19 occurring from 14 days after the 2nd dose in population
previously unvaccinated with COVID-19 vaccine.
To evaluate the protective efficacy of SCTV01E against symptomatic COVID-19 occurring from 7 days after the 3rd dose in population previously unvaccinated with COVID-19 vaccine
|
Uganda |
2022-10-28 15:05:42 |
2025-10-28 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
DAVID KITYA
ID: UNCST-2022-R009620
|
ASSESSMENT OF NEURAL TUBE DEFECTS AMONG NEWBORNS IN UGANDA: A STUDY OF PREVALENCE, RISK FACTORS, AND THE ROLE OF GENE-ENVIRONMENTAL INTERACTIONS (NTDS IN UGANDA)
REFNo: HS2479ES
Determine the proportion of newborns with neural tube defects.
2. Assess the correlation of common NTD risk factors in the development of NTDs.
3. Evaluate the environmental-gene interactions in the development of NTDs.
|
Uganda |
2022-10-28 13:30:38 |
2025-10-28 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Jackson Orem
ID: UNCST-2021-R012016
|
AMC-104, Feasibility study of ocular surface squamous neoplasia (OSSN) surgical excision in people living with HIV in sub-Saharan Africa (SSA)
REFNo: HS2366ES
To assess the feasibility of conducting multi-center prospective studies on surgical excision of suspected OSSN lesions in SSA in people living with HIV/AIDS (PLWHA).,
|
Uganda |
2022-10-28 13:28:27 |
2025-10-28 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Clovice Kankya
ID: UNCST-2020-R010154
|
Capacitating One Health in Eastern and Southern Africa (COHESA)
REFNo: SS1482ES
To understand One Health performance, capacity, and bottlenecks within Uganda,To understand Current One Health Research and Innovation within Uganda,To understand One Health challenges, gaps and capacities within Uganda,
|
Uganda |
2022-10-27 9:26:54 |
2025-10-27 |
Social Science and Humanities |
Clinical Trial |
Non-degree Award |
|
EDITH NAKKU-JOLOBA NAKKU
ID: UNCST-2021-R013931
|
MULT-COUNTRY AETIOLOGY OF GENITAL ULCER STUDY
REFNo: HS2498ES
To determine the prevalence of other sexually transmitted infections in individuals with GUD,To assess the Aetiology of genital ulcer diseases in Low and Middle Income Countries.,
|
Uganda |
2022-10-27 7:52:03 |
2025-10-27 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Isaac Ssewanyana
ID: UNCST-2020-R014336
|
STANDARD i-Q COVID-19 Ag Home Test - Laymen study including Usability.
REFNo: HS2511ES
The objective of this laymen study is to establish the usability of the STANDARD i-Q COVID-19 Ag Home Test in a self-testing environment. More specifically, the study will assess whether the instructions for use and labels are clear and understandable and whether the test can be performed correctly by laypersons.,
|
Uganda |
2022-10-27 7:48:55 |
2025-10-27 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Daniel Kibuuka Musoke
ID: UNCST-2021-R011749
|
Survey Protocol Zone of Influence Survey Uganda 2022 Feed the Future Phase Two Zone of Influence and Resilience Focus Zone Midline Indicator Assessment
REFNo: A232ES
The Midline Survey will collect primary data to generate estimates for a total of 25 indicators—14 Feed the Future P2-ZOI indicators, plus a new indicator on water security, and 10 RFZ indicators, which will only be collected in the RFZ. ,
|
Uganda |
2022-10-27 7:38:03 |
2025-10-27 |
Agricultural Sciences |
Non-Clinical Trial |
Non-degree Award |
|
David Musoke
ID:
|
Experiences of Village Taskforce members and Community Health Workers in COVID-19 prevention and control in Uganda
REFNo: HS2502ES
To assess the experiences of village task force members and community health workers (CHWs) in response to COVID-19 so as to provide information to strengthen community response to the pandemic in Uganda.
|
Uganda |
2022-10-27 7:35:53 |
2025-10-27 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|